National and Kapodistrian University of Athens
Βιολογική και ψυχολογική διερεύνηση της σεξουαλικότητας και των συντροφικών σχέσεων μετά τη θεραπεία του γυναικολογικού καρκίνου
Abstract
dc:descriptionIntroduction: Cancer diagnosis and treatment in women, especially when related to the reproductive system, may affect sexuality, and the interpersonal relationship of the couple. It is, however, difficult to discern the exact effect of cancer diagnosis and/ or treatment on the different parts of the female sexual response cycle. The aim of the present study was to record how the treatment and the adjuvant therapy of breast and gynecological cancer may affect sexuality and interpersonal relations in the couple.Materials and method: From September 2008 to February 2012, we prospectively studied 67 patients with breast cancer (Group A)(mean age 50.5 years) and 43 with cervical, endometrial or ovarian cancer (Group B)( mean age 52.6 years). As control groups we used 33 patients with benign breast and 30 patients with benign gynecological lesions (control group 0a and 0b respectively). We evaluated interpersonal relations focusing on sexual function at the time of diagnosis and a year after the initial treatment for cancer. Sexuality and interpersonal relatedness was evaluated by a self- report questionnaire. Blood was also collected to investigate the possible effect of Testosterone, Cortisol and Prolactin on sexuality.Results: More than half of the women in Group A had stage II, while the corresponding proportion for Group B was 35.9%. A significant reduction of the ‘’Sexual desire’’ dimension was found in both groups. The ‘’Sexual enjoyment’’ scale was significantly decreased in Group B but not in Group A. ‘’Sexual Arousal’’ was decreased in both groups but the degree of reduction was greater in Group B (p=0.015). The score on the ‘’Relationship quality’’ dimension increased in both groups while the score on ‘’Orgasm’’ dimensions decreased significantly in both groups (p<0.001). Hormone levels were not different between the groups at baseline measures (p>0.05). Testosterone levels remained unchanged in Group A, while they were significantly decreased in Group B (p<0.001). Thus Group A had greater Testosterone levels at follow up.Conclusion: The majority of patients in our study faced sexual dysfunctions, both immediately and one year following the end of treatment. Secondary menopause and the psychological effect of cancer treatment appeared to affect female sexual desire, while anatomical and physiological changes were found to affect arousal and orgasmic phases. Sexual dysfunctions after cancer treatment it’s a clinical problem which should be evidenced at the beginning of therapy, from the oncologists in order to provide integrated treatment.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vaidakis, Dennis
- Βαϊδάκης, Διονύσης
Subjects
dc:subject × 16- Καρκίνος μαστού
- Γυναικολογικός καρκίνος
- Σεξουαλικές διαταραχές
- Σεξουαλικές δυσλειτουργίες
- Ποιότητα σχέσης
- Breast cancer
- Gynaecological cancer
- Female sexual disorders
- Comradeship
- Sexual dysfunction
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Κλινική Ιατρική
- Medical and Health Sciences
- Basic Medicine
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/41999